Literature DB >> 33680423

The Modifiable Risk Factors of Uncontrolled Hypertension in Stroke: A Systematic Review and Meta-Analysis.

Arif Setyo Upoyo1,2, Ismail Setyopranoto3, Heny Suseani Pangastuti4.   

Abstract

OBJECTIVE: This review aimed at figuring out the risk factors of uncontrolled hypertension in stroke.
METHOD: This study systematically analyzed the hypertension risk factors available in the ProQuest, EBSCO, and PubMed databases published between 2010 and December 2019. The risk factors' pooled odds ratio (POR) included in this research was calculated using both fixed and random-effect models. The meta-data analysis was processed using the Review Manager 5.3 (Rev Man 5.3). RESULT: Of 1868 articles, seven studies were included in this review searched using specific keywords. Based on the analysis results, there were 7 risk factors of uncontrolled hypertension in stroke: medication nonadherence (POR = 2.23 [95% CI 1.71-2.89], p = 0.342; I 2 = 6.7%), use of antihypertensive drugs (POR = 1.13 [95% CI 1.19-1.59, p = 0.001; I 2 = 90.9%), stage of hypertension (POR = 1.14 [95% CI 1.02-1.27], p = <0.001; I 2 = 97.1%), diabetes mellitus (POR = 0.71 [95% CI 0.52-0.99], p = <0.001; I 2 = 96.5%), atrial fibrillation (POR = 1.74 [95% CI 1.48-2.04)], p = <0.001; I 2 = 93.1%), triglycerides (POR = 1.47 [95% CI 1.23-1.75], p = 0.879; I 2 = 0%), and age (POR = 1.03 [95% CI 0.89-1.18], p = <0.001; I 2 = 97.5%]. There were no bias publications among studies. Medication nonadherence and triglycerides had homogeneous variations, while the others had heterogeneous variations.
CONCLUSION: Medication nonadherence, triglycerides, stage of hypertension, atrial fibrillation, and use of antihypertensive drugs significantly affect the uncontrolled hypertension in stroke.
Copyright © 2021 Arif Setyo Upoyo et al.

Entities:  

Year:  2021        PMID: 33680423      PMCID: PMC7929677          DOI: 10.1155/2021/6683256

Source DB:  PubMed          Journal:  Stroke Res Treat


  23 in total

1.  Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.

Authors:  Sarah C W Marott; Sune F Nielsen; Marianne Benn; Børge G Nordestgaard
Journal:  Eur Heart J       Date:  2013-12-17       Impact factor: 29.983

Review 2.  Stroke Risk Factors, Genetics, and Prevention.

Authors:  Amelia K Boehme; Charles Esenwa; Mitchell S V Elkind
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

3.  Blood pressure control among stroke patients in Thailand--the i-STROKE study.

Authors:  Samart Nidhinandana; Disya Ratanakorn; Nijasri Charnnarong; Sombat Muengtaweepongsa; Somchai Towanabut
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-06-22       Impact factor: 2.136

4.  Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.

Authors:  Hemal Bhatt; Christopher M Gamboa; Monika M Safford; Elsayad Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-05-30

5.  Cardiovascular disease is the main cause of long-term excess mortality after ischemic stroke in young adults.

Authors:  Loes C A Rutten-Jacobs; Renate M Arntz; Noortje A M Maaijwee; Hennie C Schoonderwaldt; Lucille D Dorresteijn; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  Hypertension       Date:  2015-01-26       Impact factor: 10.190

Review 6.  Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension.

Authors:  Athanasios J Manolis; Enrico Agabiti Rosei; Antonio Coca; Renata Cifkova; Serap E Erdine; Sverre Kjeldsen; Gregory Y H Lip; Krzysztof Narkiewicz; Gianfranco Parati; Josep Redon; Roland Schmieder; Costas Tsioufis; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-02       Impact factor: 4.844

7.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Walter N Kernan; Bruce Ovbiagele; Henry R Black; Dawn M Bravata; Marc I Chimowitz; Michael D Ezekowitz; Margaret C Fang; Marc Fisher; Karen L Furie; Donald V Heck; S Claiborne Clay Johnston; Scott E Kasner; Steven J Kittner; Pamela H Mitchell; Michael W Rich; DeJuran Richardson; Lee H Schwamm; John A Wilson
Journal:  Stroke       Date:  2014-05-01       Impact factor: 7.914

8.  Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.

Authors:  Imad Abi Nasr; Anissa Bouzamondo; Jean-Sébastien Hulot; Olivier Dubourg; Jean-Yves Le Heuzey; Philippe Lechat
Journal:  Eur Heart J       Date:  2007-02-08       Impact factor: 29.983

9.  Prevalence and covariates of uncontrolled hypertension in ischemic stroke survivors: the Norwegian stroke in the young study.

Authors:  Åshild Oftedal; Eva Gerdts; Ulrike Waje-Andreassen; Annette Fromm; Halvor Naess; Anja Linde; Sahrai Saeed
Journal:  Blood Press       Date:  2018-01-15       Impact factor: 2.835

10.  Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in samarkand, uzbekistan.

Authors:  Amonov Malik; Yoshitoku Yoshida; Toirov Erkin; Davlatov Salim; Nobuyuki Hamajima
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.